The Focused Update on the Management of Patients with Atrial Fibrillation: Who Should Get What, When?
- Did you miss the live event?
Watch the video archive now »
The Focused Update on the Management of Patients with Atrial Fibrillation: Who Should get What, When? took place on Monday, March 7, 2011 6:00–7:15 p.m. ET, providing timely and relevant educational programming to key stakeholders keeping clinicians "up-to-date" on the latest research, trends and guideline recommendations pertinent to treating and caring for patients with atrial fibrillation.
Description
This 1¼ hour live webinar was moderated by Kenneth A. Ellenbogen, MD, FHRS and incorporated dynamic didactic presentations from leading physicians William G. Stevenson, MD, FHRS and Gerhard H. Hindricks, MD, Ph.D., respectively representing the writing committees from both the 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation and the Guidelines for the management of atrial fibrillation by the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
The didactic presentations were intermixed with panel discussions and live audience Q&A, which permitted direct dialogue between the esteemed faculty members and the participating attendees.
Faculty
- Kenneth A. Ellenbogen, MD, FHRS
Virginia Commonwealth University Medical Center, Richmond, VA
- Gerhard H. Hindricks, MD, Ph.D.
University of Leipzig, Leipzig, Germany
- William G. Stevenson, MD, FHRS
Brigham & Women's Hospital, Boston, MA
Faculty Disclosures (PDF, 97K)
Target Audience
The intended audience of this program includes:
- Electrophysiologist physicians and fellows
- Electrophysiologist nurses, technicians, physician assistants
- Cardiology physicians and fellows
- Cardiology nurses, technicians, physician assistants
Learning Objectives
Upon completion of this activity, participants will be able to:
- List and describe the Class I, Class IIa, and Class IIb recommendations for maintenance of sinus rhythm in instances of patients presenting paroxysmal atrial fibrillation
- Chart and distinguish the Class IIa and Class III recommendations for use of dronedarone in atrial fibrillation related to patients with Class IV heart failure, decompensated heart failure, or paroxysmal atrial fibrillation
- Explain Level of Evidence B categorization for the Class III recommendation for rate control during atrial fibrillation
- Translate up to three key recommendations outlined in the Guidelines for management of atrial fibrillation: Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) as it pertains to antithrombotic management and rate and rhythm management in relation to a minimum of three specific patient population segments
Supplementary Materials
- View video message from Douglas L. Packer, MD, FHRS, President of the Heart Rhythm Society, for more information about the 2011 Focused Update AF Guidelines
- 2011 Focused Update on the Management of Patients with Atrial Fibrillation
Download PDF now » (229K)
- Guidelines for the management of atrial fibrillation by the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Download PDF now » (3.4M)
- See also the 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran), released February 14, 2011, stating that Dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with AF — learn more
Disclosure Policy
It is the policy of the Heart Rhythm Society and American College of Cardiology to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months. The Heart Rhythm Society and American College of Cardiology implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Disclaimer
The Focused Update on the Management of Patients with Atrial Fibrillation: Who should Get What, When? webinar provides a forum for the open exchange and discussion of research results and scientific advancements in the field of cardiovascular pacing and electrophysiology; however, the Heart Rhythm Society or American College of Cardiology makes no representation or warranty as to the truth, originality, or accuracy of the information presented in this activity. Nor are the views expressed by the individual speakers necessarily the views of the Society or the College. The Heart Rhythm Society and American College of Cardiology support the ACCME's policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.
www.AFibprofessional.org is supported by a grant from
sanofi aventis and Boehringer Ingelheim.
